The US Food and Drug Administration is planning to allow Americans to get a different booster shot of a COVID-19 vaccine than the one initially taken, the New York Times reported.
The FDA in September authorised a booster dose of Pfizer Inc and partner BioNTech's two-shot COVID-19 vaccine for those aged 65 and older and some high-risk Americans.
The regulator's advisory panel has also backed the use of Moderna Inc and Johnson & Johnson's COVID-19 vaccine booster shots.
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said, citing people familiar with the agency's plans.
The FDA declined to comment on the matter.
US health officials have been under pressure to authorise the additional shots after the White House announced plans in August for a widespread booster campaign pending approvals from the FDA and the US Centers for Disease Control and Prevention.
A study by the National Institutes of Health last week showed people who got Johnson & Johnson's COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer and Moderna.
The Israeli Knesset passed a new law on Thursday that would allow the deportation of family members of people convicted of terrorist offenses, including Israeli citizens, while experts said it was aimed at Palestinians.
France accused Israel on Thursday of harming bilateral ties after Israeli security forces entered a holy site under French administration in Jerusalem and briefly detained two French officials with diplomatic status.
The United Nations has been planning for the possible return of Donald Trump and the cuts to US funding and engagement with world body that are likely to come with his second term as president.
Israeli forces stepped up bombardment across the Gaza Strip on Thursday and ordered more evacuations, creating a fresh wave of displacement from northern Gaza, to which Palestinians fear they will not be able to return.
Donald Trump's Republicans were projected to pick up another US Senate seat on Thursday and appeared to be retaining their narrow hold on the House of Representatives, putting them on track to control both chambers of Congress next year.